PSEN1 and Alzheimer disease: More recently, the researchers have focused on utilizing induced pluripotent stem cells (iPSCs) to create an AD model in vitro by transfecting cells with genes associated with early-onset Familial AD, mutant presenilin 1 (PS1), presenilin 2 (PS2) or APP.